Found: 10
Select item for more details and to access through your institution.
IL‐10 producing type 2 innate lymphoid cells prolong islet allograft survival.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 11, p. 1, doi. 10.15252/emmm.202012305
- By:
- Publication type:
- Article
Electrocatalytic N<sub>2</sub> Fixation over Hollow VO<sub>2</sub> Microspheres at Ambient Conditions.
- Published in:
- ChemElectroChem, 2019, v. 6, n. 4, p. 1014, doi. 10.1002/celc.201801484
- By:
- Publication type:
- Article
ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.638751
- By:
- Publication type:
- Article
A Biomass‐Derived Carbon‐Based Electrocatalyst for Efficient N<sub>2</sub> Fixation to NH<sub>3</sub> under Ambient Conditions.
- Published in:
- Chemistry - A European Journal, 2019, v. 25, n. 8, p. 1914, doi. 10.1002/chem.201805523
- By:
- Publication type:
- Article
S‐Doped Carbon Nanospheres: An Efficient Electrocatalyst toward Artificial N<sub>2</sub> Fixation to NH<sub>3</sub>.
- Published in:
- Small Methods, 2019, v. 3, n. 6, p. N.PAG, doi. 10.1002/smtd.201800251
- By:
- Publication type:
- Article
RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 12, p. 1, doi. 10.1038/s41419-022-05473-6
- By:
- Publication type:
- Article
Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 2, p. 1, doi. 10.1038/s41419-022-04604-3
- By:
- Publication type:
- Article
ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
- Published in:
- Cancer Science, 2021, v. 112, n. 7, p. 2714, doi. 10.1111/cas.14916
- By:
- Publication type:
- Article
UHRF1 modulates breast cancer cell growth via estrogen signaling.
- Published in:
- 2022
- By:
- Publication type:
- journal article
TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00861-z
- By:
- Publication type:
- Article